-
-
-
-
-
-
-
Dermata Therapeutics, Inc (DRMA) Misses Q2 EPS by 19c
-
-
-
-
-
-
-
RBC Capital Starts Dermata Therapeutics In (DRMA) at Outperform
-
-
-
-
-
-
-
Dermata receives Australian patent for Spongilla acne treatment technology
-
-
-
-
-
-
-
Dermata Therapeutics, Inc (DRMA) Misses Q3 EPS by 165c
-
-
-
-
-
-
-
Dermata Therapeutics, Inc (DRMA) Misses Q2 EPS by 166c
-
-
-
-
-
-
-
Dermata’s XYNGARI(TM) Phase 3 Trial Hits Statistically Significant Difference at 4 Weeks
-
-
-
-
-
-
-
Dermata to Present on BioPub on January 31, 2025
-
457,031 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

